Genertec Universal Medical Group Company Limited (HKG:2666)

Market Cap	10.41B +6.3%
Revenue (ttm)	16.18B +9.4%
Net Income	2.40B +5.0%
EPS	1.20 +6.3%
Shares Out	2.01B
PE Ratio	4.29
Forward PE	3.99
Dividend	0.36 (6.96%)
Ex-Dividend Date	Jun 12, 2025

Volume	5,157,500
Open	5.23
Previous Close	5.20
Day's Range	5.17 - 5.29
52-Week Range	5.10 - 6.71
Beta	0.59
Analysts	Strong Buy
Price Target	6.83 (+32.11%)
Earnings Date	Aug 27, 2026

About HKG:2666

Genertec Universal Medical Group Company Limited, together with its subsidiaries, provides financing, advisory, and medical services in the Mainland China. It operates through two segments, Finance Business and Healthcare Business. The Finance Business segment offers direct finance leasing; sale and leaseback; factoring; operating leases; and advisory services. Its Healthcare Business segment includes medical and healthcare services; hospital operations; import, export, and trading of medical-related goods; equipment life cycle management; medi...

• Industry: Credit Services
• Sector: Financials
• Founded: 1984
• Employees: 23,791
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 2666

Financial Performance

In 2025, HKG:2666's revenue was 14.54 billion, an increase of 9.40% compared to the previous year's 13.29 billion. Earnings were 2.16 billion, an increase of 6.15%.

Financial numbers in CNY